Latest news Back to 'Institute of Cancer and Genomic Sciences' Birmingham cancer project enters Immuno-oncology Alliance DescriptionBirmingham researchers partnered with Cancer Research UK in one of the first target identification projects for the Immuno-oncology Alliance, which translates discovery science into new therapeutics for cancer patients.Date:29/07/2021 Partnership will create the next generation of researchers to transform global healthcare DescriptionThe Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.Date:13/07/2021 University of Birmingham researcher receives award for outstanding contribution to brain tumour research DescriptionA researcher at the University of Birmingham has been named Young Investigator of the Year by the British Neuro-Oncology Society.Date:13/07/2021 COVID:19: Scientists condemn government's 'dangerous & unethical COVID-19 experiment' DescriptionUniversity of Birmingham scientists are among more than 100 experts who have signed a letter published in The Lancet urging the UK Government to reconsider its plans to abandon all COVID-19 restrictions.Date:09/07/2021 Blood cancer trial sponsored by the University of Birmingham opens for recruitment DescriptionA new clinical trial being sponsored by the University of Birmingham has opened for recruitment aiming to investigate the efficacy of a novel treatment for patients affected by a specific type of blood cancer.Date:29/06/2021 Dr Lennard Lee awarded ACP McElwain Prize for contributions to medical oncology DescriptionDr Lennard Lee, Academic Clinical Lecturer at the University of Oxford/Honorary Research Fellow at the University of Birmingham, has been awarded the 2020 Association of Cancer Physicians (ACP) McElwain Prize.Date:25/06/2021 Study finds almost half of patients with inoperable pancreatic cancer are not prescribed essential medication DescriptionA University of Birmingham-led study has found that almost half of patients with inoperable pancreatic cancer are not prescribed essential medication.Date:27/05/2021 NEC Laboratories Europe supports University of Birmingham-based InHANSE's innovative clinical cancer research DescriptionNEC Laboratories Europe has announced a donation to the University of Birmingham-based Institute of Head and Neck Studies and Education (InHANSE) to support its future cancer research.Date:13/05/2021 Bayer to invest in childhood cancer trial at the University of Birmingham DescriptionSignificant funding from Bayer enables the University of Birmingham to deliver a new study arm of an international clinical trial which aims to identify more effective treatments for a rare type of childhood cancer.Date:10/05/2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb DescriptionThe University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects that will fast track research from lab to patient.Date:06/05/2021 Displaying 1 to 10 of 161 Previous 1 2 3 4 5 … Next